Table 1.

Baseline Characteristics of CKD Participants by % Weight Change Groups (N = 872)

Variable	Weight Gain	No Intent to Lose Weight, No Weight ⊿	Intent to Lose Weight			Unintentional Weight Loss
			No Weight ⊿	5 to <10% Loss	≥10% Loss	5 to <10% Loss	≥10% Loss
	N = 117	N = 383	N = 176	N = 56	N = 35	N = 62	N = 43
	14.7%	39.8%	23.1%	7.7%	4.5%	5.5%	4.7%
Weight change (lb)	19.5 ± 9.4	0.1 ± 3.0	−0.5 ± 3.6	−15.0 ± 5.4	−33.6 ± 15.0	−12.4 ± 3.8	−36.0 ± 16.1
Weight change (%)	10.6 ± 5.1	−0.02 ± 1.63	−0.2 ± 1.9	−7.2 ± 1.1	−16.4 ± 6.4	−7.0 ± 1.6	−18.2 ± 6.8
BMI 1 y ago (kg/m2)	31.1 ± 3.9	29.6 ± 4.1	31.0 ± 4.1	34.4 ± 7.6	33.8 ± 4.5	30.1 ± 4.7	32.6 ± 4.9
Baseline BMI (kg/m2)	34.4 ± 4.6	29.6 ± 4.2	30.9 ± 4.1	31.9 ± 6.9	28.2 ± 4.1	28.0 ± 4.3	26.6 ± 4.1
Age (y)	66.9 ± 12.5	74.6 ± 9.6	68.8 ± 10.3	66.4 ± 11.0	68.2 ± 8.2	77.3 ± 9.1	72.3 ± 11.1
Male (%)	32.6	48.7	46.1	33.4	28.8	39.4	29.5
African–American race (%)	10.9	6.6	7.1	10.6	12.3	17.5	19.1
Smoking (%)	56.5	47.5	51.6	46.5	36.0	45.1	38.7
Alcohol use (%)	48.1	54.0	53.7	49.1	42.8	39.6	30.6
≥High school education (%)	66.9	62.4	75.1	73.2	62.3	48.2	46.6
Diabetes (%)	23.8	27.0	25.9	33.0	44.4	20.2	24.2
Hypertension (%)	74.2	77.8	73.4	71.7	85.9	79.8	71.7
Myocardial infarction (%)	16.3	17.4	14.4	21.4	18.9	9.2	15.7
Congestive heart failure (%)	16.7	13.1	6.3	20.9	22.4	13.2	25.0
Stroke (%)	14.1	10.9	7.7	15.2	24.9	12.9	8.0
Lung disease (%)	16.6	10.3	12.4	22.4	13.2	12.9	18.0
Cancer (%)	20.6	25.8	21.8	25.1	18.2	19.3	6.3
eGFR (mL/min/1.73 m2)	46.4 ± 10.8	48.1 ± 10.6	48.3 ± 8.9	48.8 ± 9.1	46.9 ± 10.4	45.3 ± 12.3	42.4 ± 15.5

CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.